Supplying sodium valproate safely to women and girls

25 July 2019

All members of the pharmacy team should make sure they follow the MHRA’s Pregnancy Prevention Programme (PPP) for sodium valproate every time it is dispensed. 

We spoke to two women whose children were affected by exposure to sodium valproate during their pregnancies, to find out why it’s so important to make sure that women are made aware of the risks when dispensing sodium valproate.

See the previous Regulate article on dispensing sodium valproate safely
 

Related articles

Managing concerns about pharmacy professionals: let us know your experience of fitness to practice 

22 June 2023
Help us evaluate our five-year strategy for changing the way we manage concerns about pharmacy professionals In June 2021, we published our five-year strategy- Managing concerns about pharmacy...

Take part in the RPS Inclusion and Diversity Survey

22 June 2023
The RPS would like to hear from pharmacists, pharmacy technicians and the wider pharmacy team to help contribute to the RPS’ Inclusion and Diversity Strategy. Working with partners across the system...

Patient Safety Spotlight: managing the risks associated with providing community pharmacy clinical services

24 January 2023
In this article, co-produced by one of our specialist inspectors Aileen O’Hare and Helen Williams, Consultant Pharmacist for CVD, South-East London ICS, we highlight the GPhC standards to focus on...

New Pride in Pharmacy resources

24 January 2023
Pharmacy teams have a crucial role in addressing the health inequalities faced by LGBTQ+* communities including barriers to accessing healthcare, experience of prejudice and discrimination, and...

New equality guidance for pharmacies

24 January 2023
The new guidance is designed to help tackle discrimination and ensure everyone can access safe and effective person-centred care. The new equality guidance will help support pharmacy owners and their...